Adverum Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Adverum Biotechnologies's estimated annual revenue is currently $34.3M per year.
- Adverum Biotechnologies's estimated revenue per employee is $193,750
- Adverum Biotechnologies's total funding is $648.5M.
Employee Data
- Adverum Biotechnologies has 177 Employees.
- Adverum Biotechnologies grew their employee count by 0% last year.
Adverum Biotechnologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Pipeline Strategy and External Innovation | Reveal Email/Phone |
2 | VP, Nonclinical Development | Reveal Email/Phone |
3 | VP, Clinical Affairs | Reveal Email/Phone |
4 | SVP, Quality | Reveal Email/Phone |
5 | VP Accounting | Reveal Email/Phone |
6 | SVP, Manufacturing and Supply Chain Management | Reveal Email/Phone |
7 | Head Bioanalytical Assay Development | Reveal Email/Phone |
8 | SVP, Head Global Product Strategy and Commercial | Reveal Email/Phone |
9 | VP Process Sciences | Reveal Email/Phone |
10 | VP Procurement | Reveal Email/Phone |
Adverum Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Adverum Biotechnologies?
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit www.adverum.com.
keywords:N/A
$648.5M
Total Funding
177
Number of Employees
$34.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adverum Biotechnologies News
REDWOOD CITY, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company...
REDWOOD CITY, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company...
REDWOOD CITY, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26.9M | 179 | 7% | $85.5M |
#2 | $27.2M | 181 | 21% | $37M |
#3 | $28.4M | 183 | N/A | N/A |
#4 | $58.2M | 196 | 63% | N/A |
#5 | $38M | 196 | -10% | $254M |